Pathogenesis of Central Serous ChorioRetinopathy and the Link between Choroidal Hyperpermeability and RPE Pump Reversal.

RPE pump central serous chorioretinopathy focal macular laser lucency sign photodynamic therapy

Journal

American journal of ophthalmology
ISSN: 1879-1891
Titre abrégé: Am J Ophthalmol
Pays: United States
ID NLM: 0370500

Informations de publication

Date de publication:
06 May 2024
Historique:
received: 12 02 2024
revised: 09 04 2024
accepted: 26 04 2024
medline: 9 5 2024
pubmed: 9 5 2024
entrez: 8 5 2024
Statut: aheadofprint

Résumé

To describe 6 cases of acute central serous chorioretinopathy (CSCR) and the response to laser treatment, focusing on the underlying pathogenic mechanism. Multimodal imaging from 6 eyes of 6 patients with acute and recurrent CSCR were reviewed including fundus autofluorescence (FAF), fluorescein angiography (FA), indocyanine green angiography (ICGA) and optical coherence tomography (OCT) at baseline and after laser therapy. In 3 out of the 6 cases with acute CSCR, the hyporeflective lucency sign was identified with cross sectional and en face OCT and co-localized with an intense active inkblot retinal pigment epithelium (RPE) leak on FA. The development of this sign was suggestive of active leakage into the subretinal space displacing overlying subretinal hyperreflective material (SHRM) and suggestive of a reversal of RPE pump function. All six cases were treated with focal laser to directly target the intense leakage points with remarkable resolution of the fluid due to destruction of the RPE cells mediating reversal of pump function. Unlike chronic CSCR in which degenerative changes of the RPE lead to oozing of fluid into the subretinal space, in acute forms of CSCR including bullous CSCR, there are focal leaks of the RPE that actively drive fluid into the subretinal space suggestive of RPE pump reversal. We propose that pachychoroid disease causes increased hydrostatic pressure and increased resistance to the RPE pump thereby triggering a reversal in pump function. Understanding this concept can have therapeutic implications.

Identifiants

pubmed: 38719133
pii: S0002-9394(24)00181-8
doi: 10.1016/j.ajo.2024.04.025
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Federica Fossataro (F)

Retinal Disorders and Ophthalmic Genetics Division, Stein Eye Institute David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, USA; Department of Ophthalmology, ASST Fatebenefratelli, Sacco, Milan, Italy.

Claudia Fossataro (C)

Retinal Disorders and Ophthalmic Genetics Division, Stein Eye Institute David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, USA; Ophthalmology Unit, Catholic University of the Sacred Heart, Rome, Italy; Ophthalmology Unit, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy.

Neda Abraham (N)

Retinal Disorders and Ophthalmic Genetics Division, Stein Eye Institute David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, USA.

Yousef Fouad (Y)

Ophthalmology Department, Ain Shams University Hospitals, Cairo, Egypt.

Sarah Mrejen (S)

Centre Hospitalier National Ophtalmologique des 15-20, Paris, France.

Anna Cs Tan (AC)

Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore; Ophthalmology & Visual Sciences Academic Clinical Program (Eye ACP), Duke-NUS Medical School, Singapore, Singapore.

Shilo Voichaski (S)

Retinal Disorders and Ophthalmic Genetics Division, Stein Eye Institute David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, USA; Vitreoretinal Division, Ophthalmology Department, Shaare Zedek Medical Center, Jerusalem, Israël.

David Sarraf (D)

Retinal Disorders and Ophthalmic Genetics Division, Stein Eye Institute David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, USA; Greater Los Angeles VA Healthcare Center, Los Angeles, California, USA. Electronic address: dsarraf@ucla.edu.

Classifications MeSH